Equities research analysts at StockNews.com began coverage on shares of Calithera Biosciences (NASDAQ:CALA – Get Free Report) in a research report issued on Saturday. The firm set a “hold” rating on the biotechnology company’s stock.
Calithera Biosciences Price Performance
CALA opened at $0.01 on Friday. The stock’s 50-day moving average price is $0.01 and its 200 day moving average price is $0.01. Calithera Biosciences has a 12-month low of $0.00 and a 12-month high of $0.12.
About Calithera Biosciences
Want More Great Investing Ideas?
Read More
- Five stocks we like better than Calithera Biosciences
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- What is a Stock Market Index and How Do You Use Them?
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
